Blau Farmacêutica S.A.

Blau Farmacêutica is a prominent Brazilian multinational pharmaceutical company and a pioneer in biotechnology within the region. It specializes in the development, production, and commercialization of high-complexity drugs, primarily serving the institutional and hospital segments. Its portfolio spans critical therapeutic areas including immunology, hematology, oncology, nephrology, infectious diseases, and anesthesiology. The company operates a robust industrial complex featuring five pharmaceutical plants in Brazil and an Active Pharmaceutical Ingredient (API) production facility. Blau maintains a significant continental footprint with operations across seven South American countries and plasma collection centers in the United States, alongside strategic interests in European plasma fractionation.